Blood Pressure Lowering Effect of Hypertension Treatment Device Further Validated in N...( New research continues to reinfor...),Health

New research continues to reinforce the efficacy of RESPeRATE while

highlighting interest in the device by the scientific community

BERLIN and NEW YORK, June 16 /PRNewswire/ -- European Society of Hypertension -- Booth # 21, Hall 15.1 -- InterCure Ltd., a medical device company publicly traded on the Tel-Aviv Stock Exchange (TASE: INCR), today announced the findings of new studies and analysis highlighting RESPeRATE -- the only medical device cleared by the FDA and CE-approved for the treatment of hypertension. Five posters will be presented at the European Society of Hypertension meeting (ESH) in Berlin beginning June 14, 2008. Two of the five posters focus on RESPeRATE's effect on blood pressure as measured by 24-hour ambulatory blood pressure monitoring. Three of the posters also present new findings in the emerging field of obtaining vascular risk parameters from blood pressure measurements. The fifth poster demonstrates the benefits of RESPeRATE in patients with chronic heart failure.

"InterCure is making great strides within the European marketplace and has received a tremendous response from both the scientific and consumer communities," says Erez Gavish, president and CEO of InterCure. "The continued clinical interest is producing a constant drumbeat of validation for RESPeRATE, paving the path for the successful charge into retail outlets in Europe and the U.S. and building on the more than 100,000 hypertension sufferers who have already adopted RESPeRATE as a treatment for their hypertension."

Results of the findings related to RESPeRATE are being presented as posters at ESH and are as follows:

-- PS26/WED/05 -- A study performed in Turkey, led by Prof. Erdine,

Department of Cardiology, Istanbul University, demonstrated that the

RESPeRATE device provides daytime and nighttime blood pressure

reductions as measured by 24-hour ambulatory monitoring. The study

also demonstra
'/>"/>